October 25th, 2014


Volume 45
Number 7
   
529
Alex C. Vidaeff, M.D., and Catherine Racowsky, Ph.D.
Day 5 blastocyst transfers are recommended for patients at increased risk of high-order multiple gestations, whereas for poor-prognosis patients, day 3 embryo transfer is still advisable.


539
William F. Rayburn, M.D.
Day 5 blastocyst transfers are recommended for patients at increased risk of high-order multiple gestations, whereas for poor-prognosis patients, day 3 embryo transfer is still advisable.


541
John J. Klutke, M.D., Jonathan Bergman and Carl G. Klutke, M.D.
Transvaginal bladder neck suspension with Cooper's ligament fixation is an effective surgical option in the treatment of genuine stress incontinence.


546
Peter S. Bernstein, M.D., M.P.H., Tani Sanghvi, M.D., M.P.H., and Irwin R. Merkatz, M.D.
The combination of education about preconception care and insertion of a standardized form into a patient's chart led to a clear improvement in the documentation of preconception care.


553
Gary M. Horowitz, M.D., Scott Christensen, M.D., Caroline Kennebeck, M.D., and R. Leon Graham, M.D.
This animal model suggests that endometrial ablation does not decrease the risk of endometrial carcinoma in patients at high risk of developing endometrial pathology.


557
Margaret Echt, M.D., Wallace Begneaud, M.D., and Douglas Montgomery, M.D.
Elective epidural analgesia for labor pain relief was associated with no increase in the primary cesarean delivery rate and increases in the forceps delivery and vaginal birth after cesarean rates.


562
Brendan C. Carroll, M.D., and Joseph P. Bruner, M.D.
Avoiding intervention in pregnancies with oligohydramnios and normal umbilical artery Doppler velocimetry may decrease iatrogenic morbidity due to prematurity by as much as 26%.


567
JosČ L. Bartha, M.D., Rafael Comino-Delgado, M.D., Pilar Martinez-Del Fresno, M.D., MarĖa J. Ortega, M.D., JosČ R. Fernandez-Lorente, M.D., and Juan M. Cabello, M.D.
The percentage of B lymphocytes was lower in primiparas who had normal pregnancies in comparison to women who had never been pregnant.


572
Capt Cynthia Goldstein McNally, MC, USAF, Maj Thomas C. Krivak, MC, USAF, and Turgut Alagoz, M.D.
After a hysterectomy, conservative management of an isolated postoperative fever is safe.


577
Jennifer Cassisi, M.D., John D. Davis, M.D., Barbara B. Bennett, M.D., Frederick W. McLean, M.D., and Robert B. Marcus, Jr., M.D.
For rare patients with dysfunctional uterine bleeding, intracavitary radiotherapy may be a treatment option.


581
Vern L. Katz, M.D., Richard Farmer, M.D., Ph.D., John York, M.D., and John D. Wilson, M.D.
When chronic parenteral therapy is required for hyperemesis gravidarum, indwelling catheters should be removed as soon as possible.


585
Elyce H. Cardonick, M.D., Jaan Naktin, M.D., and Vincenzo Berghella, M.D.
This patient's biopsy was performed without intraoperative or postoperative complications and aided her diagnosis and therapy.


588
Limor Gortzak-Uzan, M.D., Eyal Sheiner, M.D., and Josef Gohar, M.D.
Early-first-trimester prenatal diagnosis by first-trimester chorionic villus sampling or second-trimester measuring of alkaline phosphatase activity in the amniotic fluid is required to exclude this lethal disease in subsequent pregnancies.


591
Franco Causio, M.D., Domenico Canale, M.D., Luca Maria Schonauer, M.D., Rita Fischetto, M.D., Teresa Leonetti, M.D., and Nicoletta Archidiacono, Ph.D.
This is the first report documenting a chromosomal pericentric inversion with disruption in the DAZ gene area.


595
John C. Riggs, M.D., Antoine Jahshan, M.D., and Henry J. Schiavello, M.D.
Foley balloon tamponade in conjunction with uterine eversion, placental site excision and methotrexate was successful in treating intraoperative hemorrhage from placenta accreta.


599
Vidya Soundararajan, M.D., and Jodie Rai, M.D.
A rudimentary uterine horn presented during pregnancy, mimicking ectopic pregnancy, and was removed laparoscopically.


603
Richard L. Harvey, M.D., George Mychaskiw II, D.O., Vishal Sachdev, M.D., and Bobby J. Heath, M.D.
All women with myocardial abnormalities and a history of squamous cell carcinoma of the cervix should be suspected of developing a myocardial metastasis until proven otherwise.


607
Jason H. Collins, M.D.


607
  


 

The opinions and statements in this journal are those of the authors and are not attributable to the sponsor, publisher, editors or editorial board of JRM. Product dosages, indications and methods of use referred to in the papers and discussions reflect the authors' clinical experience or are derived from other professional sources.